Neuroendocrine Tumor Grade 2
8 clinical trials · Condition
◉ Watch Neuroendocrine Tumor Grade 2
| Record | Firm | Date |
|---|---|---|
| CapTemY90 for Grade 2/3 NET Liver Metastases (NCT04339036) | Abramson Cancer Center at Penn Medicine | 2021-10-07 |
| Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN (REBORN) (NCT04464122) | University of Roma La Sapienza | 2020-09-14 |
Track Neuroendocrine Tumor Grade 2 automatically
Every clearance here is in the API, with alerts when new ones post.